Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
Press Releases

Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share

Board of Directors of Revance Recommend Stockholders Tender their Shares

avatar profile Olean Times Herald

Olean Times Herald


Local & Social